Subscribe to the "News" RSS Feed 
TOP
- J&J found not liable in…
Johnson & Johnson on Thursday won a lawsuit brought by…
- Choosing Glaxo’s Cervarix saves UK…
Britain’s decision to choose GlaxoSmithKline Plc’s Cervarix cervical cancer…
- Antidepressants linked to non-Hodgkin lymphoma
Long-term users of so-called tricyclic antidepressants are at increased risk…
- Epilepsy drug eases diabetic neuropathy…
A review of previous studies indicates that the seizure drug…
- New Medications May Offer Hope…
Individuals who experience the physical, mental and social symptoms associated…
- NIAID will not move forward…
After soliciting and considering broad input from the scientific and…
- Drug prevents bone loss in…
Amgen Inc on Monday said that a trial of its…
- U.S. FDA staff questions J&J…
U.S. drug reviewers have “several major concerns” about the…
- Combo therapy improves outcome for…
A regimen that integrates treatments for high blood pressure (hypertension)…
- Intel gets FDA OK for…
Intel Corp, the world’s biggest computer chip maker, said…
- New US drug marketing code…
Come next year, doctors may start to see a problem…
- Prescription drugs easily purchased online:…
Despite new efforts to regulate Internet pharmacies, 85 percent of…
- FDA changing notices on drug…
U.S. regulators will change the way they tell drugmakers that…
- Osteoporosis drug linked to fractures
Prolonged use of Fosamax, also referred to by the generic…
- Antihypertensive treatment on cognitive functions…
Dementia is one of the major challenges of the 21st…
